INS and type 1 diabetes mellitus: At present, the therapeutic effect of SOTA on TIDM is satisfactory.[11] Literature supports that SOTA can reduce the HbAlc of T1DM patients, reduce the use of insulin does, and bring more patients to the standard.[12,13] However, SOTA may cause kinds of serious adverse events.[14] Among the common adverse reactions are urinary tract infection and genital infection.